The evidence regarding the effect of coffee on cancer of the mouth, pharynx and larynx is judged as 'limited -- no conclusion\' ([@bib16]). Coffee is not mentioned among the food and nutritional factors that may modify the risk of cancer in the oesophagus. However, high-temperature drinks are judged as 'limited -- suggestive\' in increasing the risk ([@bib16]). A recent prospective study from Japan found an inverse relationship between coffee dose and the risk of oral, pharyngeal and oesophageal cancers ([@bib9]). One prospective study from Norway found no relationship, whereas another study found an inverse relationship between coffee consumption and incidence of cancer in the buccal cavity and pharynx ([@bib4]; [@bib13]). The Japanese and the two Norwegian studies are the only prospective studies on this subject as far as we know.

Some case--control studies have found an inverse relationship ([@bib14]; [@bib11]), but not all ([@bib6]; [@bib10]). An update on coffee and cancer risk concluded that 'epidemiological data indicate an inverse relation between coffee, liver and probably oral and oesophageal cancers\' ([@bib7]). A recent pooled analysis of nine case--control studies of head and neck cancers with 5139 cases concluded with a support of the hypothesis of an inverse association between caffeinated coffee drinking and risk of cancer of the oral cavity and pharynx ([@bib2]). So did a meta-analysis by [@bib15] based on 2633 cases. These cancers are serious with a 5-year relative survival of \<10% for oesophageal cancer and around 50% for oral cancer in Norway ([@bib1]). It is thus of great importance to obtain evidence of preventive measures of these cancers. We conducted a prospective study, including close to 400 000 participants aged 40--45 years.

Materials and methods
=====================

Study population
----------------

During 1985--1999, a cardiovascular survey programme was carried out in Norway. All men and women aged 40--42 years were invited. All counties, except for the capital Oslo, were visited every third year and each time a new cohort aged 40--42 was invited. In a few counties, a sample of people aged 43--45 years was invited. The attendance rate declined from close to 80% in the beginning down to nearly 60% at the end. Altogether 395 291 individuals participated in the surveys. We excluded 4603 who were registered as having cancer before attending the screening. In addition, 1064 did not answer the coffee questions, leaving 389 624 for analysis. Of these, 130 593 (33%) answered the question on alcohol, which was introduced in 1994.

Variables
---------

The study protocol was the same throughout the study period. Height and weight were measured to the nearest centimetre and half kilo. Underwear, stockings and trousers were allowed, but not shoes.

The questionnaire included questions on coffee consumption, smoking habits, cardiovascular history, diabetes history and physical activity. From 1994, questions about alcohol consumption were included and from 1997, a question about the consumption of fruit and vegetables was included. The questions about coffee were 'How many cups of coffee do you usually drink a day?\' with preset categories; none or \<1, 1--4, 5--8, 9+ cups. 'What type of coffee do you usually drink each day?\' with preset categories; boiled coffee, filtered coffee, instant coffee, decaffeinated coffee and don\'t drink coffee. From 1994, the questions were changed to 'How many cups of boiled coffee do you usually drink a day?\' and 'How many cups of other types of coffee do you usually drink a day?\' The participants filled in the actual number of cups. We categorised the number of cups according to the preset categories 0 or \<1, 1--4, 5--8 and 9+ cups per day, coded as 1, 2, 3, 4, respectively. We then categorised the subjects into drinkers of boiled coffee and drinkers of other types. Note that drinkers of boiled coffee may also drink other types, whereas the 'other types\' group does not include any boiled coffee drinkers.

The question on physical activity during leisure time had four alternatives from sedentary to intensive. However, during 1994--1997 (∼22% of the study population), we asked about the number of hours of strenuous activity (sweating/out of breath) with four categories from none to 3+ hours per week. We have defined those in the lowest category of either question as sedentary.

The questions on alcohol read 'How many glasses of (1) beer (2) wine (3) spirits do you usually drink every 2 weeks?\'. For each type, the actual number of glasses was filled in. In addition, there was a question on teetotalism (yes, no). In Norway, an alcohol unit is defined as 15 ml (12.8 g). This corresponds to a bottle (33 cl) of beer (4.5%), a glass (15 cl) of wine (12.0%) and a small glass (4 cl) of spirits (40%). We estimated the number of units per month by adding the number of glasses stated and multiplying by 2. We defined the categories as follows: (1) teetotaller, (2) not teetotaller, but 0 units per month, (3) \<10 units per months and (4) 10+ units per month.

We defined five smoking categories as follows: (1) never smokers, (2) ex-smokers, (3) 1--19 cigarettes per day, (4) 20+ cigarettes per day and (5) others. People who smoked a pipe or cigars, but not cigarettes, made up the 'others\' group.

Body mass index was categorised as \<20, 20--24, 25--29, 30+ kg m^--2^.

Information on educational level was collected from a national register in Statistics Norway by linkage as described beneath (end points). High education was defined as 13 or more years of education.

Statistical analysis
--------------------

The participants accrued person years from the date of their examination during the national survey to the date of first cancer, death, emigration or 31 December 2007.

Hazard ratios were estimated by Cox proportional hazards regressions with person years as the time variable. Smoking, body mass index, alcohol consumption and coffee intake were entered as dummy variables, according to the abovementioned categorisation and with never smokers, \<20 kg m^--2^, teetotallers and 1--4 cups per day, respectively, as reference categories. When testing for trend, coffee was entered as a continuous variable coded as 1, 2, 3, 4. Equality of means or proportions across coffee groups was tested by analysis of variance or by χ^2^ statistics from contingency tables, respectively. *P-*values \<0.05 were considered statistically significant and all tests were two sided.

This study has a 90% power to detect a hazard ratio of 0.83 between two adjacent coffee groups. When taking the correlation between the coffee and smoking groups into account, the power is reduced to 87% when smoking is adjusted for. The power is 90% to detect a hazard ratio of 0.77 on half the study population.

End points
----------

Information on cancer was taken from the Cancer Registry of Norway by linkage using the encrypted personal identification number attributed to each inhabitant in Norway.

We used malignant neoplasm of buccal cavity or oesophagus (ICD-7 140--148, 150) as end point, restricted to squamous cell carcinoma (morphology codes 8050--8080, International Classification of Diseases for Oncology, Edition 3), which made up 93% of all cancers in mouth and oesophagus. We also did separate analyses for squamous cancers in the oesophagus (ICD-7 150) and in the mouth (ICD-7 140--148).

Altogether 450 people had cancer of the buccal cavity or oesophagus, distributed as cancer of lip (*n*=61), tongue (*n*=85), salivary gland (*n*=33), floor of mouth (*n*=28), other parts of mouth or unspecified (*n*=36), oral mesopharynx (*n*=88), nasopharynx (*n*=5), hypopharynx (*n*=16), pharynx unspecified (*n*=2) and oesophagus (*n*=96). In multivariate analyses, there were 446 end points due to missing information on confounders in some individuals. In the subgroup who had answered the alcohol questions, there were 75 end points, 74 in multivariate analyses.

Results
=======

[Table 1](#tbl1){ref-type="table"} shows baseline characteristics of age, smoking habits, body mass index and for the relevant subgroup, alcohol intake. Men were in the majority in the highest coffee consumption group and in the minority in the other coffee groups. About 20% smoked in the lowest coffee dose group increasing to \>70% among people who drank nine or more cups per day. The proportion of boiled coffee use and daily smoking increased with the number of cups, whereas the proportion with high education decreased to less than half in the highest as compared with the lowest coffee dose group. The proportion of physically active people was also lowest in the highest coffee dose group. Alcohol consumption did not vary much in the three upper coffee groups, whereas the consumption of alcohol was less in the 0 or \<1 cup group.

The hazard ratios varied between 0.96 and 1.16 in the coffee groups with no distinct trend ([Table 2](#tbl2){ref-type="table"}). Stratification by sex, smoking and type of coffee revealed no distinct pattern. It is noted, however, that there is a positive trend among the non-smokers with a *P*-value for the trend slightly smaller than 0.05. However, this could be expected by chance when doing multiple testing, and testing for interaction between smoking (yes/no) and coffee consumption gave no significance (*P*=0.08).

The lack of a consistent trend with coffee dose persisted when specifically using oral and oesophageal cancers as end point ([Table 3](#tbl3){ref-type="table"}).

Additional adjustment for alcohol in the subsample with information on alcohol consumption (the 33% of the study population, which entered in the period 1994--1999) had virtually no impact on the coffee--cancer association ([Table 4](#tbl4){ref-type="table"}).

Information on fruit and vegetables was available for 17% of the study population (those who were examined in 1997--1999). The proportion who consumed fruit/vegetables daily varied marginally between the three lowest coffee dose groups, whereas the proportion in the 9+ cups was lower in both men and women (data not shown).

Discussion
==========

In this large study of middle-aged men and women, we found no relationship between coffee dose and cancer of the buccal cavity, pharynx and oesophagus.

There have been some studies on this topic, but with ambiguous results. In a recent update from 13 studies, [@bib7] reported that 12 of these found no association between coffee intake and cancers of the oral cavity, pharynx and oesophagus.

On the other hand, in a short report from two case--control studies, it was concluded that 'coffee may decrease the risk of oral/pharyngeal and esophageal cancer\'. A coffee dose of 3+ cups was compared with \<1 cup per day ([@bib14]).

Cancer in the oral cavity and oesophagus is a rare disease in young people. [@bib11] found that high consumption of coffee (3+ cups per day) was inversely related to risk of oral and pharyngeal cancer below age 46. Interestingly, this study revealed an inverse relationship with body mass index, but as the authors state, this may be due to reverse causation.

A recent prospective study from Japan found 50% lower risk for oral, pharyngeal and oesophageal cancers for users of ⩾1 cup per day as compared with no users ([@bib9]). The exposure groups in that study (never use, occasional use and ⩾1 cup per day) are practically non-overlapping with the exposure groups in our study. The Japanese study compares low dose with no dose, whereas our study compares high dose with low dose.

Quite recently, a study of pooled individual-level data from nine case--control studies was published ([@bib2]). The findings supported the hypothesis of an inverse association between caffeinated coffee drinking and oral and pharyngeal cancer. The odds ratio of \>4 cups per day *vs* zero cups per day varied between 0.5 and 0.7 in various strata of geography, education, tobacco consumption, alcohol consumption and vegetable and fruit intake, which are quite consistent results. The authors claimed that recall bias of coffee consumption was not likely, as coffee consumption was not known to be related to head and neck cancers. On the other hand, recall bias on smoking habits and alcohol intake may well have taken place. It is hard to assess the impact on the risk estimates of recall bias of confounders. A meta-analysis by [@bib15] on eight case--control studies and one observational study found a relative risk of 0.64 comparing the highest and lowest coffee consumption groups.

There are many examples that case--control studies more readily reveal associations than prospective studies do. One reason is that case--control studies are more likely to be encumbered with bias such as recall bias. Besides the Japanese study, we know of two prospective studies, both from Norway ([@bib4]; [@bib13]). None of these consistently supported an inverse association, but [@bib13] reported a borderline significant inverse association with cancer of the buccal cavity and pharynx in men.

Regarding the tendency for different findings in case--control and prospective studies, another example is the relation between coffee consumption and colorectal cancer. One meta-analysis of case--control studies suggested a favourable moderate effect of coffee consumption on colorectal cancer ([@bib3]). Another meta-analysis on prospective studies found no relationship ([@bib5]). On the other hand, there was a slight suggestion of an inverse association in some of the studies, and this suggestion was stronger in studies with shorter follow-up. The upshot might be reverse causation since people with disease symptoms might reduce their coffee consumption. We checked this possibility in our study population by estimating hazard ratios based on 5 years follow-up (77 cases). There was no tendency of lower hazard ratios (data not shown).

Our study is by far the largest prospective study as measured by the number at risk. Potential confounders have been taken into account and the follow-up is nearly complete using the National Cancer Registry and the Cause of Death Registry as end point registries. The Cancer Registry of Norway reports a completeness of 98.8% for the period 2001--2005 except for haematological malignancies and cancer of the central nervous system. For the period 2003--2007, 97.6% of the cancers in mouth and pharynx (ICD-10 C10-C14) and 95.0% of the oesophageal cancers (ICD-10 C15) were morphologically verified. ([@bib1]).

Limitations
-----------

We have to keep in mind that this data set is from a systematic screening over a 15-year period with a primary focus on cardiovascular disease.

We have no information about what people added to the coffee, such as milk or sugar. These ingredients have not been linked to oral--oesophageal cancers, but milk might influence the temperature of the coffee that is consumed in a favourable way with regard to the risk of oesophageal cancer. However, the Expert Report Panel judged the evidence of high-temperature drinks as a cause of oesophageal cancer as limited ([@bib16]).

Another weakness is that we only have information on alcohol consumption in a subgroup and on fruit and vegetable consumption in an even smaller subgroup. These questions were introduced when the programme had been running for 9 and 12 years, respectively. The counties were visited every third year, when new cohorts of 40--42-year olds were invited. This means that the subgroups with information on alcohol and fruit/vegetables were born later and represent a minor selection of counties compared with the total study population, but there is no reason to believe that the distribution of alcohol dose and the prevalence of daily use of fruit or vegetables in the subgroups deviated from that in the total study population. Alcohol and fruit/vegetables have both been related to cancer risk; fruit and vegetables in a favourable way ([@bib8]), and alcohol in an unfavourable way (World Cancer research fund). Our data from the subgroups with fruit/vegetables and alcohol indicate that these variables were not important confounders in our study. Nevertheless, the fact remains that we have not been able to adjust the entire study population for alcohol consumption and dietary intake of fruit and vegetables.

A proportion of smokers may have stopped smoking during follow-up. The official surveys show that the smoking prevalence in ages 15--74 years has declined from 35% in 1991 to 25% in 2006 ([@bib12]). However, this would not influence the adjusted estimates of the coffee--cancer association unless smoking cessation depended on baseline coffee consumption or affected later coffee consumption.

As mentioned, we do not know what people put in their coffee. Other factors that may vary between studies are type of coffee (in Norway Coffee Arabica L), ways of preparing the coffee and size of cup. However, stratified analyses give no reason to believe that differences in the type of coffee or brewing methods can explain the conflicting results between our study and the majority of case--control studies. The power of our study was high to detect a hazard ratio of 0.8 between two adjacent coffee groups. But we cannot exclude a weak inverse relationship.

This study does not support an inverse relationship between coffee intake and cancers in the buccal cavity, pharynx and oesophagus.

The authors declare no conflict of interest.

###### Baseline characteristics

                                 **0, \<1 cup per day**   **1--4 cups per day**   **5--8 cups per day**   **9+ cups per day**
  ----------------------------- ------------------------ ----------------------- ----------------------- ---------------------
  *N*                                    41 454                  153 376                 150 724                44 070
  Age (mean)                              41.3                    41.4                    41.4                   41.4
  Men, %                                  46.0                    43.4                    49.4                   61.1
  Boiled, %                               4.4                     26.4                    31.0                   36.3
  High education, %                       30.4                    28.7                    20.4                   12.1
  Physically active, %                    78.3                    81.6                    78.4                   69.7
                                                                                                                    
  *Smoking,* %                                                                                           
   Never                                  45.9                    39.3                    25.2                   13.7
   Ex                                     34.7                    33.0                    25.4                   14.7
   \<20 cig                               14.5                    23.0                    37.1                   40.7
   20+ cig                                4.6                      4.4                    11.5                   30.5
   Smoke, not cig                         0.2                      0.3                     0.5                    0.5
                                                                                                                    
  *BMI (kg* *m*^*--2*^*), %*                                                                             
   \<20                                   5.3                      4.7                     4.5                    4.5
   20--24                                 49.7                    52.0                    49.4                   46.2
   25--29                                 33.5                    34.4                    37.4                   39.2
   30+                                    11.5                     8.8                     8.6                   10.1
                                                                                                                    
  *Alcohol,* %                                                                                           
   *N* (with info on alcohol)            14 812                  48 445                  49 361                 17 975
    Teetotallers                          19.3                     8.6                     6.6                    6.0
    0 units per month                     29.0                    20.3                    21.6                   24.4
    \<10 units per month                  27.3                    34.9                    31.5                   28.1
    10+ units per month                   24.0                    36.0                    40.2                   41.4

Abbreviations: BMI=body mass index; cig=cigarettes.

Men and women 40--45 years.

###### Adjusted HR[a](#t2-fn2){ref-type="fn"} with 95% CI of squamous oral--oesophageal cancer by daily coffee consumption

                     **0, \<1 cup**   **1--4 cups**   **5--8 cups**   **9+ cups**   **HR per 1 unit**   ***P-*trend**
  ----------------- ---------------- --------------- --------------- -------------- ------------------- ---------------
  *All*                                                                                                 
   Cases                   35              139             207             69                            
   Pyrs                 580 385         2 213 629       2 184 454       619 489                          
   HR                     1.01             Ref            1.16            0.96      1.02                0.79
   95% CI             (0.70, 1.47)                    (0.93, 1.45)    (0.71, 1.31)  (0.90, 1.14)         
                                                                                                         
  *Men*                                                                                                 
   Cases                   30              87              148             60                            
   Pyrs                 271 137          975 204        1 089 176       379 842                          
   HR                     1.33             Ref            1.24            1.11      1.01                0.88
   95% CI             (0.88, 2.02)                    (0.95, 1.63)    (0.78, 1.58)  (0.88, 1.16)         
                                                                                                         
  *Women*                                                                                               
   Cases                   5               52              59              9                             
   Pyrs                 309 248         1 238 424       1 095 277       239 647                          
   HR                     0.42             Ref            1.04            0.57      1.03                0.78
   95% CI             (0.17, 1.05)                    (0.71, 1.53)    (0.27, 1.20)  (0.82, 1.30)         
                                                                                                         
  *Non-smokers*                                                                                         
   Cases                   18              77              66              15                            
   Pyrs                 466 172         1 586 749       1 091 824       172 339                          
   HR                     0.78             Ref            1.14            1.51      1.22                0.043
   95% CI             (0.47, 1.30)                    (0.82, 1.59)    (0.87, 2.64)  (1.01, 1.47)         
                                                                                                         
  *Smokers*                                                                                             
   Cases                   17              62              141             54                            
   Pyrs                 114 212          626 880        1 092 630       447 150                          
   HR                     1.43             Ref            1.19            0.87      0.91                0.24
   95% CI             (0.84, 2.45)                    (0.88, 1.61)    (0.60, 1.27)  (0.79, 1.06)         
                                                                                                         
  *Boiled coffee*                                                                                       
   Cases                   2               39              74              32                            
   Pyrs                  30 669          611 247         703 807        231 139                          
   HR                     0.88             Ref            1.26            1.17      1.10                0.40
   95% CI             (0.21, 3.64)                    (0.85, 1.87)    (0.71, 1.92)  (0.88, 1.39)         
                                                                                                         
  *Other coffee*                                                                                        
   Cases                   33              100             133             37                            
   Pyrs                 549 715         1 602 381       1 480 646       388 350                          
   HR                     1.01             Ref            1.11            0.83      0.98                0.73
   95% CI             (0.68, 1.51)                    (0.85, 1.54)    (0.56, 1.24)  (0.85, 1.12)         

Abbreviations: CI=confidence interval; HR=hazard ratios; Pyrs=person years.

Adjusted for sex (except when stratified by sex), daily smoking (except in non-smokers), body mass index and education.

###### Adjusted HR[a](#t3-fn2){ref-type="fn"} with 95% CI of subtypes of squamous oral--oesophageal cancer by daily coffee consumption

                  **0, \<1 cup**   **1--4 cups**   **5--8 cups**   **9+ cups**    **HR per 1 unit**   ***P-*trend**
  -------------- ---------------- --------------- --------------- -------------- ------------------- ---------------
  *Buccal*                                                                                                   
   Cases                29              114             158             53                                   
   Pyrs              580 385         2 213 629       2 184 454       619 489                                 
   HR                  1.03             Ref            1.12            0.96             1.01              0.92
   95% CI          (0.68, 1.55)                    (0.88, 1.44)    (0.68, 1.36)     (0.88, 1.15)             
                                                                                                             
  *Oesophagus*                                                                                               
   Cases                6               25              49              16                                   
   Pyrs              580 385         2 213 629       2 184 454       619 489                                 
   HR                  0.93             Ref            1.34            0.97             1.06              0.67
   95% CI          (0.38, 2.26)                    (0.82, 2.18)    (0.50, 1.88)     (0.82, 1.36)             

Abbreviations: CI=confidence interval; HR=hazard ratios; Pyrs=person years.

Adjusted for sex, daily smoking, body mass index and education.

###### Adjusted HR with 95% CI of squamous oral--oesophageal cancer by daily coffee consumption in the subgroup where questions on alcohol were included

                                                      **0--4 cups**   **5+ cups**    ***P-*value**
  -------------------------------------------------- --------------- -------------- ---------------
  Cases                                                    28              46               
  Pyrs                                                   648 566        704 146             
  HR[a](#t4-fn2){ref-type="fn"}                            Ref            0.98           0.93
  95% CI                                                   ---        (0.59, 1.61)          
  HR with alcohol units[b](#t4-fn3){ref-type="fn"}         Ref            0.98           0.94
  95% CI                                                   ---        (0.59, 1.62)          

Abbreviations: CI=confidence interval; HR=hazard ratios; Pyrs=person years.

Adjusted for sex, daily smoking, body mass index and education.

Adjusted for sex, daily smoking, body mass index, education and alcohol consumption.
